SCHEMBL1442648

SCHEMBL1442648

COC(=O)c1ccccc1-c1ccc2ncc(N3CCOCC3)nc2c1.COc1cccc(-c2ccc3ncc(N4CCOCC4)nc3c2)c1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ MTOR P42345 4/20 0.43
▸ PRKDC P78527 2/20 0.43
▸ PIK3CD O00329 1/20 0.43
▸ PIK3CA P42336 1/20 0.43
▸ PIK3CB P42338 1/20 0.43
▸ PIK3CG P48736 1/20 0.43
▸ PIK3C3 Q8NEB9 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1442484 0.92 HCRTR1 (0.43) PIK3CAMEN1ALDH1A1KMT2ANPC1
SCHEMBL12812422 0.91 PRKDC (0.49) CYP1A2CYP2C19CYP2D6CYP2C9TDP1
SCHEMBL12812437 0.90 ATR (0.49) CYP1A2CYP2C19CYP2D6MTORPRKDC
SCHEMBL1442713 0.82 ALDH1A1 (0.61) CYP1A2CYP2C19CYP2D6TDP1MTOR
SCHEMBL12812446 0.81 HPGD (0.49) PIK3CAMEN1ALDH1A1KMT2AHCRTR1
SCHEMBL12812447 0.80 PTPN11 (0.46) CYP1A2CYP2C19CYP2D6PIK3CAMEN1
SCHEMBL12811951 0.80 HPGD (0.45) CYP1A2MTORPRKDCPIK3CDPIK3CA
SCHEMBL1442987 0.80 ALDH1A1 (0.50) CYP1A2CYP2C19MTORPRKDCPIK3CD
SCHEMBL1442982 0.78 ATR (0.49) CYP1A2CYP2C19CYP2D6MTORPRKDC
SCHEMBL1442476 0.78 TNIK (0.54) CYP1A2CYP2C19MTORPRKDCPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2473498-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS Bayer Pharma Aktiengesellschaft (DE) 2012-07-11 — — EP claimed
WO-2011026579-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-10 — — WO claimed
Send feedback